At this high-level roundtable event alongside the World Health Assembly, we will debate the progress on the WHO Immunization Agenda 2030 in relation to life-course immunisation.

The WHO Immunization Agenda 2030 (IA2030) sets out “A Global Strategy to Leave No One Behind”, with an action plan which focuses on the importance of life-course immunisation. The IA2030 goals are designed to inspire action for implementation and support efforts to improve health security, universal health coverage, access and equity for immunization and innovation.

But how much progress has been made and what needs to happen next?

Vaccination is a key component of healthy ageing, as highlighted by the Immunisation for All Ages (IFAA) initiative, of which ILC is a member.

During the event, we will explore how we can best

• Prioritise life course immunisation as a key pillar of expanded prevention strategies and a central component of universal health coverage.
• Remove barriers to access for appropriate immunisation to ensure all people are protected and no one is left behind.
• Reduce inequities in timely, appropriate, and affordable access to immunisation throughout life.

During the event, we will also present evidence from new global ILC research on

• The cost effectiveness of life course immunisation
• Adult vaccination in Japan
• Life-course vaccination in central and Eastern Europe
• Pneumococcal vaccination in at risk groups

This project has been made possible by an unrestricted educational grant from Pfizer.

Session slides